A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-05-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a 24 hour patch test to determine the acute tolerance of 3 variants of condom on a panel of healthy adult subjects. The patches will be affixed to the back and remain under occlusion for 24 hours. They will then be assessed at 30 minutes and 24 hours post patch removal.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Randomised Controlled Trial of Condoms Plus Additional Lubrication

NCT00369213

Contraception

COMPLETED PHASE4

Evaluation of Tolerance and Acceptability of a Coated Condom

NCT01619397

Tolerance and Acceptability of a New Condom Coating

COMPLETED NA

Evaluation of a Novel Female Hygiene Device for Postcoital Discomfort

NCT04885556

Vaginal Discharge Dyspareunia Female Sexual Dysfunction +2 more

UNKNOWN NA

Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis

NCT02314429

Vaginosis, Bacterial

COMPLETED PHASE1

A Clinical Investigation to Assess the Performance of Natural Rubber Latex Condoms in Couples

NCT03739190

Control of Pregnancy Prevention of Sexually Transmitted Infections

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Three test products (plus positive and negative control) will be applied to the back using occlusive tape and will remain on the skin for 24 hours. The patches will be removed after 24 hours and assessed as 30 minutes post patch removal and again at 24 hours post patch removal. Each test site will be scored for erythema and oedema by a dermatologist.

The primary endpoint for this Clinical Investigation is the irritation of the test products according to the Cutaneous Irritancy Index value. The test products success criteria is to be graded as 'non-irritant' and this should be confirmed by the study dermatologist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Other

This is a safety study where a marketed product will be placed on healthy adult skin.

Group Type OTHER

Condom

Intervention Type DEVICE

This study involves testing a condom, however the device will not be used as intended. The device will be destroyed to make the test patches required for this safety study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Condom

This study involves testing a condom, however the device will not be used as intended. The device will be destroyed to make the test patches required for this safety study.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Durex

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects who are able to give written informed consent and from whom written informed consent has been obtained
* Generally healthy male or female subjects between the ages of 18 and 70 years inclusive.
* Subjects assessed by the dermatologist as having normal/healthy skin.
* Subjects with skin Phototype I to IV skin.
* Subjects who have been exposed to Natural Rubber Latex through condom use with no allergic reaction being raised
* Subjects, who are able to understand the study, co-operate with the study procedures (including no swimming during the study period) and are able to attend all study assessments.

Exclusion Criteria

* Female subjects who are pregnant, lactating or have given birth within the previous 3 months or are planning to be pregnant during the study.
* Female subjects of childbearing potential who, for the duration of the study, are either unwilling or unable to take adequate contraceptive precautions or are unwilling to be sexually abstinent.
* Subjects with previous experience of intolerance or allergic reactions to any components of the test products including latex and lubricants.
* Subjects with either form of diabetes.
* Subjects with an active skin disorder or a significant history of skin disorders (e.g. psoriasis, eczema, vitiligo, pityriasis versicolor, acne) which in the opinion of the Principle Investigator or dermatologist may affect the test results
* Subjects whose skin has been excessively exposed to the sun or to UV rays during the previous month in the opinion of the Investigator.
* Subjects who are suffering from chronic asthma, a malfunction of the lymphatic system or an autoimmune deficiency diseases (e.g. lupus, thyroiditis).
* Subjects with very easily irritated/sensitive skin in the opinion of the Investigator.

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes